Annual Meeting of the Japanese Society of Toxicology
34rd Annual Meeting of the Japanese Society of Toxicology
Session ID : SY4-1
Conference information

Preclinical Evaluation of Anti-cancer Drugs
Preclinical development of a new alkylating agent: Temozolomide
*Kenji Shirahashi
Author information
CONFERENCE PROCEEDINGS FREE ACCESS

Details
Abstract
[in Japanese]
Content from these authors
© 2007 The Japanese Society of Toxicology
Previous article Next article
feedback
Top